TEE 1482
Alternative Names: TEE-1482Latest Information Update: 31 May 2023
At a glance
- Originator APTEEUS
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Farber lipogranulomatosis; Myoclonic epilepsies; Spinal muscular atrophy
Most Recent Events
- 29 Mar 2023 Clinical trials in Farber lipogranulomatosis in France (unspecified route) (APTEEUS pipeline, March 2023)
- 29 Mar 2023 Clinical trials in Myoclonic epilepsies in France (unspecified route) (APTEEUS pipeline, March 2023)
- 29 Mar 2023 Clinical trials in Spinal muscular atrophy in France (unspecified route) (APTEEUS pipeline, March 2023)